It is the most common type of glaucoma, a set of eye diseases that affect the eye's optic nerve. The optic nerve is located at the back of the eye and sends visual messages to the brain.

Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, Chapel Hill. As a board-certified ophthalmologist, she specializes in ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma ...

Vision loss can happen for several reasons, and for most dogs, it is a gradual process. Some dogs may develop eye conditions ...

Led by Professor Hao F. Zhang, the center will advance its work by developing cutting-edge tools to better understand and ...

The Glaucoma Center of San Francisco is excited to announce the first treatment of a patient in the U.S. with the non-invasive Eyetronic nerve stimulating therapy. Eyetronic therapy provides external ...

COLUMBIA, S.C. — It’s as if she’s squinting through a smoke-filled room. But it’s Charisse Brown’s eye condition, glaucoma, that diminishes her vision.

Optic nerve damage can lead to vision loss and eventual blindness. The good news is that it’s possible to prevent or slow the progression of vision loss associated with glaucoma.

Some 200 million people worldwide are experiencing vision loss as a result of it, he said. People with diabetic retinopathy and glaucoma may also potentially be benefited by this research.